Opdivo Singled Out in Government Rule Change
The suggestion of government orchestration against Ono’s immunotherapy treatment Opdivo (nivolumab) has moved a stage further with a report in the...
5.9k Views
JPX Margin Trading Weekly (Dec 5th): Carta, Toyoda Gosei, Lasertec, Advantest, SoftBank, Mitsui E&S
We analyzed JPX margin trading positions report for the past week and highlighted Carta (3688 JP), Toyoda Gosei (7282 JP), Lasertec (6920 JP),...
388 Views
Japan: Moving Average Outliers - Tech[nical] Rebound
- MARKET COMPOSITE - SLOW & STEADY RECOVERY - From December 25th's lows of 8% by number and 11% by value, the percentages of Japanese stocks...
720 Views
Japan: Relative Price Score Update - Overbought and Oversold Companies
RELATIVE PRICE SCORE - The Relative Price Score (RPS) measures stock price performance relative to TOPIX and is calculated by comparing the current...
637 Views
Nipro [8086 JP] - A Serial Destroyer of Shareholder Value on the Acquisition Trail
INVENTORY WATCHLIST OUTLIER - Nipro Corp (8086 JP) appeared on our list of larger cap companies where Inventory Cash Flow is excessive relative to...
336 Views